Neuroimmune Dysfunction in Alcohol Use Disorder
Public ClinicalTrials.gov record NCT04210713. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Characterization of Neuroimmune Dysfunction in Alcohol Use Disorder
Study identification
- NCT ID
- NCT04210713
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Enrollment
- 142 participants
Conditions and interventions
Conditions
- Alcohol Drinking
- Alcohol-Related Disorders
- Alcoholism
- Anti-Bacterial Agents
- Anti-Infective Agents
- Chemically-Induced Disorders
- Cognition Disorder
- Cognitive Dysfunction
- Disease
- Drinking Behavior
- Inflammation
- Mental Disorder
- Minocycline
- Neurocognitive Disorders
- Pathologic Processes
- Substance-Related Disorders
Interventions
- Minocycline Drug
- Sugar pill Drug
Drug
Eligibility (public fields only)
- Age range
- 25 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2, 2020
- Primary completion
- Sep 19, 2023
- Completion
- Sep 19, 2023
- Last update posted
- Nov 30, 2023
2020 – 2023
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Maryland Psychiatric Research Center (MPRC) Treatment Research Program (TRP) | Catonsville | Maryland | 21228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04210713, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 30, 2023 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04210713 live on ClinicalTrials.gov.